Abbott Laboratories (ABT)
107.35
+0.49
(+0.46%)
USD |
NYSE |
Apr 26, 10:58
Abbott Laboratories Revenue (Quarterly): 9.964B for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.964B |
| December 31, 2023 | 10.24B |
| September 30, 2023 | 10.14B |
| June 30, 2023 | 9.978B |
| March 31, 2023 | 9.747B |
| December 31, 2022 | 10.09B |
| September 30, 2022 | 10.41B |
| June 30, 2022 | 11.26B |
| March 31, 2022 | 11.90B |
| December 31, 2021 | 11.47B |
| September 30, 2021 | 10.93B |
| June 30, 2021 | 10.22B |
| March 31, 2021 | 10.46B |
| December 31, 2020 | 10.70B |
| September 30, 2020 | 8.853B |
| June 30, 2020 | 7.328B |
| March 31, 2020 | 7.726B |
| December 31, 2019 | 8.314B |
| September 30, 2019 | 8.076B |
| June 30, 2019 | 7.979B |
| March 31, 2019 | 7.535B |
| December 31, 2018 | 7.765B |
| September 30, 2018 | 7.656B |
| June 30, 2018 | 7.767B |
| March 31, 2018 | 7.39B |
| Date | Value |
|---|---|
| December 31, 2017 | 7.589B |
| September 30, 2017 | 6.829B |
| June 30, 2017 | 6.637B |
| March 31, 2017 | 6.335B |
| December 31, 2016 | 5.333B |
| September 30, 2016 | 5.302B |
| June 30, 2016 | 5.333B |
| March 31, 2016 | 4.885B |
| December 31, 2015 | 5.188B |
| September 30, 2015 | 5.15B |
| June 30, 2015 | 5.17B |
| March 31, 2015 | 4.897B |
| December 31, 2014 | 5.356B |
| September 30, 2014 | 5.079B |
| June 30, 2014 | 5.057B |
| March 31, 2014 | 4.755B |
| December 31, 2013 | 5.014B |
| September 30, 2013 | 4.825B |
| June 30, 2013 | 5.446B |
| March 31, 2013 | 5.378B |
| December 31, 2012 | 3.188B |
| September 30, 2012 | 5.265B |
| June 30, 2012 | 5.313B |
| March 31, 2012 | 5.284B |
| December 31, 2011 | -7.067B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
7.328B
Minimum
Jun 2020
11.90B
Maximum
Mar 2022
9.789B
Average
10.12B
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 3.725B |
| Stryker Corp | 5.815B |
| Intuitive Surgical Inc | 1.891B |
| Insulet Corp | 509.80M |
| Edwards Lifesciences Corp | 1.534B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.225B |
| Total Expenses (Quarterly) | 8.578B |
| EPS Diluted (Quarterly) | 0.70 |
| Enterprise Value | 193.05B |
| Gross Profit Margin (Quarterly) | 55.21% |
| Profit Margin (Quarterly) | 12.29% |
| Earnings Yield | 2.99% |
| Operating Earnings Yield | 3.39% |
| Normalized Earnings Yield | 3.006 |